Cooperative Clinical Trial of Photodynamic Therapy for Early Gastric Cancer with Photofrin Injection(R) and YAG-OPO Laser
1998

Photodynamic Therapy for Early Gastric Cancer

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): SEISHIRO MIMURA, HIROYUKI NARAHARA, TOSHIO HIRASHIMA, HISAYUKI FUKUTOMI, AKIRA NAKAHARA, HIROMASA KASHIMURA, HIROFUMI MATSUI, HIROSHI TANIMURA, YUGO NAGA, SHIGERU SUZUKI, YOKO MURATA, KAZUNARI YOSHIDA, KAICHI ISONO, TERUO KOZU, HIROKO IDE, HARUBUMI KATO

Primary Institution: Osaka Medical Center for Cancer and Cardiovascular Diseases

Hypothesis

Can photodynamic therapy using a YAG-OPO laser effectively treat early gastric cancer?

Conclusion

The YAG-OPO laser is suitable as an excitation light source for photodynamic therapy in treating early gastric cancer.

Supporting Evidence

  • Complete responses were obtained in 75% of assessable patients.
  • All cases with mucosal carcinoma had a 100% response rate.
  • One patient experienced mild photosensitivity lasting several weeks.
  • Decrease of total protein was observed in 40% of patients.

Takeaway

Doctors used a special light to help treat stomach cancer in 12 patients, and it worked really well for most of them.

Methodology

The study evaluated the effects of photodynamic therapy using Photofrin and a YAG-OPO laser in 12 patients with early gastric cancer.

Limitations

The study had a small sample size and only included patients with specific tumor characteristics.

Participant Demographics

{"median_age":68.5,"sex_distribution":{"male":10,"female":2},"performance_status":{"0":9,"2":2,"3":0,"4":0}}

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication